OrbiMed Advisorsraised a combined $4.3 billion for its ninth flagship heath care VC fund, its fifth Asia-focused fund, and its fourth royalties and credit opportunities fund.
Why it matters: New York-basedOrbiMed's fresh dry powder could inject some life into a muted funding environment for health tech.